The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RAS activation and CDKN2A deletion to predict prognosis in cancer of unknown primary.
 
Tilmann Bochtler
No Relationships to Disclose
 
Anna Reiling
No Relationships to Disclose
 
Volker Endris
Honoraria - AstraZeneca; Thermo Fisher Scientific
Consulting or Advisory Role - Novartis/Pfizer
 
Thomas Hielscher
No Relationships to Disclose
 
Anna-Lena Volckmar
Consulting or Advisory Role - AstraZeneca; AstraZeneca
 
Olaf Neumann
No Relationships to Disclose
 
Martina Kirchner
No Relationships to Disclose
 
Jan Budczies
No Relationships to Disclose
 
Lukas Heukamp
Employment - Hämatopathologie Hamburg; NEO New Oncology
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Roche Pharma AG
 
Jonas Leichsenring
Honoraria - AstraZeneca
Expert Testimony - AstraZeneca
 
Michael Allgäuer
No Relationships to Disclose
 
Peter Schirmacher
Honoraria - AstraZeneca; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst)
 
Albrecht Stenzinger
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Illumina; Novartis; Thermo Fisher Scientific
Speakers' Bureau - AstraZeneca; Bayer; Bristol-Myers Squibb; Illumina; MSD; Novartis; Roche; Thermo Fisher Scientific
Research Funding - Bristol-Myers Squibb; Chugai Pharma
 
Alwin Kraemer
No Relationships to Disclose